TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System
December 17 2020 - 08:45AM
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a
global company specializing in disinfection and decontamination,
utilizing its premier Binary Ionization Technology (BIT) platform
through its SteraMist products - a hydrogen peroxide-based mist and
fog composed of ionizedHydrogen Peroxide (iHP), today announced
that it has received a follow-on order from ITH Pharma Limited
(ITH), for the integration of a second SteraMist Custom Engineered
System (CES) into their facility.
ITH is an industry leader in aseptic compounding services,
mixing drugs into ready-to-use IV preparation, applicable to every
area of therapy and strives to set new standards in supplying
specialized, manufactured products to medical professionals and
their patients. The company must comply with stringent
decontamination levels as required by regulatory agencies such as
the Medicines and Healthcare products Regulatory Agency (MHRA), and
with this order it has purchased an additional SteraMist 8
applicator CES to service their new facility, following initial
success with a CES in use with their other refurbished facility.
This additional complete room system is in addition to the fleet of
8 Environment Systems initially purchased by ITH, many of which
have been recently relocated to an area specifically designated for
the manufacturing of COVID-19 testing supplies under the Centers
for Disease Control (CDC) procedures. The SteraMist CES utilizes
the backbone of all SteraMist equipment: Binary Ionization
Technology (BIT) and is permanently mounted into facilities
allowing for complete connection to building automation.
Dr. Halden Shane, CEO of TOMI, commented, “We are excited to
work with ITH for an additional CES installation. We have a
longstanding relationship with ITH, who recognized the value of our
solution early on and was one of the first clients of our Life
Sciences division. It can be a time consuming endeavor to adhere to
all the GMP and regulatory requirements imposed on pharmaceutical
facilities, and we appreciate every opportunity to work with our
customers to continue supporting their efforts in both the pandemic
and medical supply through our growing range of SteraMist
products.”
As an EPA-registered solution to be used exclusively with
SteraMist technology, recurring BIT Solution sales are a
cornerstone of TOMI’s revenue. Starting in 2021, CES and
Environment Systems maintained by ITH Pharma Limited present the
opportunity for recurring orders of 100 gallons per month of BIT
Solution. These recurring orders allow facilities to maintain
uninterrupted focus on specialized operations while also meeting
stringent standards in protocols set by agencies such as the
National Health Service of the United Kingdom.
TOMI™ Environmental Solutions, Inc.: Innovating for a
safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a
global decontamination and infection prevention company, providing
environmental solutions for indoor surface disinfection through the
manufacturing, sales and licensing of its premier Binary Ionization
Technology® (BIT™) platform. Invented under a defense grant in
association with the Defense Advanced Research Projects Agency
(DARPA) of the U.S. Department of Defense, BIT™ solution
utilizes a low percentage Hydrogen Peroxide as its only active
ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™).
Represented by the SteraMist® brand of products, iHP™ produces a
germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of
commercial structures, including, but not limited to, hospitals and
medical facilities, cruise ships, office buildings, hotel and motel
rooms, schools, restaurants, meat and produce processing
facilities, military barracks, police and fire departments, and
athletic facilities. TOMI products and services have also
been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols
for its clients and is a member in good standing with The American
Biological Safety Association, The American Association of Tissue
Banks, Association for Professionals in Infection Control and
Epidemiology, Society for Healthcare Epidemiology of America,
America Seed Trade Association, and The Restoration Industry
Association.
For additional information, please
visit http://www.tomimist.com/ or contact us
at info@tomimist.com.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute
“forward-looking statements” as defined in the Private Securities
Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking
statements are identified by such words and phrases as “we expect,”
“expected to,” “estimates,” “estimated,” “current outlook,” “we
look forward to,” “would equate to,” “projects,” “projections,”
“projected to be,” “anticipates,” “anticipated,” “we believe,”
“could be,” and other similar phrases. All statements addressing
operating performance, events, or developments that we expect or
anticipate will occur in the future, including statements relating
to revenue growth, earnings, earnings-per-share growth, or similar
projections, are forward-looking statements within the meaning of
the Reform Act. They are forward-looking, and they should be
evaluated in light of important risk factors that could cause our
actual results to differ materially from our anticipated results.
The information provided in this document is based upon the facts
and circumstances known at this time. We undertake no obligation to
update these forward-looking statements after the date of this
release.
INVESTOR RELATIONS CONTACTJohn Nesbett/Jennifer BelodeauIMS
Investor
Relationsjnesbett@imsinvestorrelations.com203.972.9200
TOMI Environmental Solut... (NASDAQ:TOMZ)
Historical Stock Chart
From Feb 2024 to Mar 2024
TOMI Environmental Solut... (NASDAQ:TOMZ)
Historical Stock Chart
From Mar 2023 to Mar 2024